Elevated brain monoamine oxidase activity in SIV-and HIV-associated neurological disease

35Citations
Citations of this article
25Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We recently demonstrated direct evidence of increased monoamine oxidase (MAO) activity in the brain of a simian immunodeficiency virus (SIV) model of human immunodeficiency virus (HIV)-associated central nervous system (CNS) disease, consistent with previously reported dopamine deficits in both SIV and HIV infection. In this study, we explored potential mechanisms behind this elevated activity. MAO B messenger RNA was highest in macaques with the most severe SIV-associated CNS lesions and was positively correlated with levels of CD68 and GFAP transcripts in the striatum. MAO B messenger RNA also correlated with viral loads in the CNS of SIV-infected macaques and with oxidative stress. Furthermore, in humans, striatal MAO activity was elevated in individuals with HIV encephalitis, compared with activity in HIV-seronegative controls. These data suggest that the neuroinflammation and oxidative stress caused by SIV infection in the CNS may provide the impetus for increased transcription of MAO B and that MAO, and more broadly, oxidative stress, have significant potential as therapeutic targets in CNS disease due to HIV. © The Author 2014.

Cite

CITATION STYLE

APA

Meulendyke, K. A., Ubaida-Mohien, C., Drewes, J. L., Liao, Z., Gama, L., Witwer, K. W., … Zink, M. C. (2014). Elevated brain monoamine oxidase activity in SIV-and HIV-associated neurological disease. In Journal of Infectious Diseases (Vol. 210, pp. 904–912). Oxford University Press. https://doi.org/10.1093/infdis/jiu194

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free